Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP840506.RACkXTjj5Gm57v0QxdmWhwQzV75TtmirV-5Z9MD76Wfxk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP840506.RACkXTjj5Gm57v0QxdmWhwQzV75TtmirV-5Z9MD76Wfxk130_assertion type Assertion NP840506.RACkXTjj5Gm57v0QxdmWhwQzV75TtmirV-5Z9MD76Wfxk130_head.
- NP840506.RACkXTjj5Gm57v0QxdmWhwQzV75TtmirV-5Z9MD76Wfxk130_assertion description "[The pharmacodynamic effects of seliciclib, a cyclin-dependent kinase (CDK) inhibitor, were studied in patients with nasopharyngeal carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP840506.RACkXTjj5Gm57v0QxdmWhwQzV75TtmirV-5Z9MD76Wfxk130_provenance.
- NP840506.RACkXTjj5Gm57v0QxdmWhwQzV75TtmirV-5Z9MD76Wfxk130_assertion evidence source_evidence_literature NP840506.RACkXTjj5Gm57v0QxdmWhwQzV75TtmirV-5Z9MD76Wfxk130_provenance.
- NP840506.RACkXTjj5Gm57v0QxdmWhwQzV75TtmirV-5Z9MD76Wfxk130_assertion SIO_000772 19228744 NP840506.RACkXTjj5Gm57v0QxdmWhwQzV75TtmirV-5Z9MD76Wfxk130_provenance.
- NP840506.RACkXTjj5Gm57v0QxdmWhwQzV75TtmirV-5Z9MD76Wfxk130_assertion wasDerivedFrom befree-20140225 NP840506.RACkXTjj5Gm57v0QxdmWhwQzV75TtmirV-5Z9MD76Wfxk130_provenance.
- NP840506.RACkXTjj5Gm57v0QxdmWhwQzV75TtmirV-5Z9MD76Wfxk130_assertion wasGeneratedBy ECO_0000203 NP840506.RACkXTjj5Gm57v0QxdmWhwQzV75TtmirV-5Z9MD76Wfxk130_provenance.